Study-Related Publications

1. Greene MH, Mai PL. What have we learned from risk-reducing salpingo-oophorectomy? J Natl Cancer Inst 2009; 101(2):70-71.
2. Greene MH, Piedmonte M, Alberts D, Gail M, Hensley M, Miner Z, Mai PL, Loud J, Rodriguez G, Basil J, Boggess J, Schwartz PE, Kelley JL, Wakeley KE, Minasian L, Skates S. A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer. Design and baseline characteristics: A Gynecologic Oncology Group Study. Cancer Epidemiol Biomarkers Prev 2008; 17(3):594-604.
3. Alberts DS, Walker J, Rodriguez G, Garcia FAR, Mutter GL, Palxe S, Carlson J, Hensley M, Hess LM, Method MM, Greene MH, Barakat RR. Chapter 9 – Prevention of Gynecologic Cancer. in The Gynecologic Oncology Group: Report of 35 Years of Excellence In Clinical Research (DiSaia P, editor), XXIV Century Press, Inc, pp 60-72, 2006.
4. Lacey JV, Jr., Greene MH, Buys SS, Reding D, Riley TL, Berg CD, Fagerstrom RM, Hartge P. Ovarian cancer screening in women with a family history of breast or ovarian cancer. Obstet Gynecol 2006;108(5):1176-1184.
5. Buys SS, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL, Hartge P, Fagerstrom RM, Ragard LR, Chia D, Izmirlian G, Fouad M, Johnson CC, Gohagan JK. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol 2005;193(5):1630-1639.
6. Brewer MA, Ranger-Moore J, Baruche A, Alberts DS, Greene MH, Thompson D, Liu Y, Davis J, Bartels PH. Exploratory study of ovarian intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 2005;14(2):299-305.
7. Brewer MA, Ranger-Moore J, Greene MH, Alberts DS, Liu Y, Bartels HG, Baruch AC, Bartels PH. Preneoplastic changes in ovarian tissues. Anal Quant Cytol Histol 2004;26(4):207-216.
8. Modugno F and the Ovarian Cancer and High-risk Women Symposium Presenters, including Greene MH. Ovarian cancer and high-risk women-implications for prevention, screening, and early detection. Gynecol Oncol 2003;91(1):15-31.